Scholars Central

Conference abstract

Bioequivalence study of Levofloxacin in healthy Kazakhs volunteers

Authors: Shnaukshta V.S

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Levofl oxacin is a synthetic chemotherapeutic antibiotic drug which is used for treatment of bacterial infections. Th ere are many Levofl oxacin generic drugs in Kazakhstan and relative bioavailability is important as it shows the drug quality. Th erefore has been studied BA/BE of the test formulation Levolet (T) and reference formulation Tavanic (R) containing of Levofl oxacin 500 mg tablets aft er single dose oral administration under fasting condition. Volunteers were healthy Kazakh adults randomly assigned to receive T- and R- formulation or vs. with a 1-week washout period between doses. A total of 18 participants were enrolled including 7 men and 11 women at the age of 28 years (range 19-40 years). Levofl oxacin plasma concentrations were determined by HPLS assay using UV detection. For the analysis of pharmacokinetic parameters, including Cmax, AUC 0-24, AUC 0-∞ and Cmax/ AUC 0−24 , blood samples were collected at baseline and at 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12, and 24 hours aft er oral administration of the drugs. Th e test formulations were considered to meet the criteria for bioequivalence if the geometric mean ratios (T/R) were in the range of 80% to 125%. Mean relative bioavailability was 100.3%. Th e 90% CIs of the mean of the diff erence between log-transformed values for Cmax, AUC 0-24 and AUC 0- ∞ were 93.3% to 104%, 93% to 105% and 91% to 107%, respectively. Th is study shows that there is no signifi cant diff erence in kinetic parameters between two products. Th erefore, these two formulations are considered to be bioequivalent.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutica Analytica Acta
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Shnaukshta V.S”